FDA
-
-
-
-
-
-
-
Abeona adds Children's Hospital of Philadelphia for ZEVASKYN treatment
-
-
-
-
-
-
-
Abeona Therapeutics appoints Keith Goldan to board of directors
-
-
-
-
-
-
-
Abeona Therapeutics® Provides Business Update Highlighting Building Momentum in ZEVASKYN® Commercial Launch
-
-
-
-
-
-
-
Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in Texas
-
-
-
-
-
-
-
Abeona receives permanent J-code for ZEVASKYN gene therapy
-
-
-
-
-
-
-
Abeona gene therapy selected for FDA rare disease pilot program
-
-
-
-
-
-
-
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
328,151 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

